The Enterprise Value as of June 2026 (TTM) for Sutro Biopharma, Inc. (STRO) is 218.65M

According to Sutro Biopharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 218.65M. This represents a change of 89.70% compared to the average of 115.26M of the last 4 quarters.

Sutro Biopharma, Inc. (STRO) Historical Enterprise Value (quarterly & annually)

How has STRO Enterprise Value performed in the past?

The mean historical Enterprise Value of Sutro Biopharma, Inc. over the last ten years is 235.74M. The current 218.65M Enterprise Value has changed 9.18% with respect to the historical average. Over the past ten years (40 quarters), STRO's Enterprise Value was at its highest in in the March 2021 quarter at 1.01B. The Enterprise Value was at its lowest in in the March 2026 quarter at -56791199.07.

Sutro Biopharma, Inc. (STRO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sutro Biopharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sutro Biopharma, Inc. (STRO) Average Enterprise Value

How has STRO Enterprise Value performed in the past?

The current Enterprise Value of Sutro Biopharma, Inc. (STRO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Sutro Biopharma, Inc. (STRO) Enterprise Value vs. Peers

How is STRO’s Enterprise Value compared to its peers?

Sutro Biopharma, Inc.’s Enterprise Value is greater than Artiva Biotherapeutics, Inc. (200.39M), greater than Adverum Biotechnologies, Inc. (159.14M), greater than Precision BioSciences, Inc. (7.35M), greater than Pliant Therapeutics, Inc. (76.56M), greater than Fractyl Health, Inc. Common Stock (59.01M), greater than InflaRx N.V. (85.69M), greater than Metagenomi, Inc. Common Stock (59.06M), greater than Connect Biopharma Holdings Limited (95.83M), greater than Shattuck Labs, Inc. (148.26M), greater than Kalaris Therapeutics Inc (47.97M),

Build a custom stock screener for Sutro Biopharma, Inc. (STRO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sutro Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sutro Biopharma, Inc. (STRO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sutro Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.